- AstraZeneca Plc AZN has filed suit against former VP and head of investor relations Chris Sheldon as he prepares to start a new job at GSK plc GSK in September, Bloomberg reported.
- In a London court filing, AstraZeneca argued that Sheldon would be violating a non-compete agreement, which he was paid more than $774,000 in shares to sign in 2021, Bloomberg reported.
- Sheldon worked at AstraZeneca for more than 18 years. He resigned earlier this month, effective immediately, according to Law360.
- According to the Bloomberg report, GSK poached Sheldon and another senior dealmaker to boost its cancer therapies and other drugs pipeline.
- Sheldon was tasked with identifying late-stage deal opportunities.
- AstraZeneca previously headed to court to protect its interests after a senior executive left for a close rival. In 2017 it sued former executive Luke Miels who also moved to GSK.
- AstraZeneca and GSK settled in court, with Miels taking a “gardening leave” until joining GSK in September 2017.
- However, according to The Times in London, Miels accused Soriot of threatening him over his visa during the resignation dispute.
- Price Action: GSK shares are down 2.52% at $34.37, and AZN stock is up 0.90% at $67.34 on the last check Wednesday.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.